Aquestive Therapeutics (AQST) Current Leases (2020 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Current Leases of $662000.0 for Q1 2026, up 22.59% year-over-year from $540000.0 in Q1 2025, and up 4.91% quarter-over-quarter from $631000.0 in Q4 2025.
Aquestive Therapeutics (AQST) Current Leases (2020 - 2026) Analysis & Trends
Aquestive Therapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $662000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 22.59% year-over-year to $662000.0; the TTM figure through Mar 2026 stood at $662000.0 (up 22.59% YoY), while the FY2025 annual figure was $631000.0, up 23.73% from the prior year.
- Current Leases for Q1 2026 stood at $662000.0, up from $631000.0 in the prior quarter.
- The five-year high for Current Leases was $926000.0 in Q1 2022, with the low at $255000.0 in Q4 2022.
- The 5-year median for Current Leases is $510000.0 (2024), against an average of $543352.9.
- The sharpest annual moves came in 2022 and 2023: Current Leases slumped 71.64% in 2022, then jumped 52.94% in 2023.
- Aquestive Therapeutics' Current Leases stood at $255000.0 in 2022, then soared by 52.94% to $390000.0 in 2023, then soared by 30.77% to $510000.0 in 2024, then gained by 23.73% to $631000.0 in 2025, then advanced by 4.91% to $662000.0 in 2026.
- Business Quant data shows AQST's Current Leases at $662000.0 in Q1 2026, $631000.0 in Q4 2025, and $601000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Aquestive Therapeutics | 554.85 Mn | 554.85 Mn | 9.80 Mn | 820,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 820,000.00 |
| Mar 31, 2026 | 662,000.00 |
| Dec 31, 2025 | 631,000.00 |
| Sep 30, 2025 | 601,000.00 |
| Jun 30, 2025 | 570,000.00 |
| Mar 31, 2025 | 540,000.00 |
| Dec 31, 2024 | 510,000.00 |
| Sep 30, 2024 | 482,000.00 |
| Jun 30, 2024 | 455,000.00 |
| Mar 31, 2024 | 414,000.00 |
| Dec 31, 2023 | 390,000.00 |
| Sep 30, 2023 | 367,000.00 |
| Jun 30, 2023 | 347,000.00 |
| Mar 31, 2023 | 328,000.00 |
| Dec 31, 2022 | 255,000.00 |
| Sep 30, 2022 | 846,000.00 |
| Jun 30, 2022 | 913,000.00 |
| Mar 31, 2022 | 926,000.00 |
| Dec 31, 2021 | 899,000.00 |
| Sep 30, 2021 | 860,000.00 |